Results for cancer biomarker discovery
-
cyclacel.com
Cyclacel Pharmaceuticals, Inc. | Biopharmaceutical company developing cell cycle control c
Cyclacel is a biopharmaceutical company, based in Berkeley Heights, New Jersey and Dundee, Scotland, that develops orally available small molecule drugs which target various cell cycle phases to control cancer and other serious diseases.
-
oncologybiomarkers-congress.com
Oxford Global Conferences – Oncology Biomarkers Congress – 14-15 October 2013,
Leading Oncology Biomarkers Congress in Europe showcasing Companion Diagnostic Development, Oncology Biomarker Clinical Strategy and Oncology Biomarker Case Studies
-
bencoslife.com
BENCOS we care life
A life science company and we nurture life
-
sbhdiagnostics.com
SBH Diagnostics
SBH Diagnostics is an innovative CLIA Lab for Simple Western CRO Service, EASy-Sjogren's Test and more.
-
xeptagen.com
Xeptagen - Life Biotechnology & Life Nanotechnology
Discovery and validation of novel molecular markers to produce innovative diagnostic kits for early detection, monitoring, and screening of cancerous cells
-
eugenleo.net
Kontakt
Consulting firm
-
oncologyexperts.net
Kontakt
Consulting firm
-
xeptagen.net
Xeptagen - Life Biotechnology & Life Nanotechnology
Discovery and validation of novel molecular markers to produce innovative diagnostic kits for early detection, monitoring, and screening of cancerous cells
-
molecularmetabo.com
Molecular Metabolism LLC. | Formerly NextGen Sciences | protein biomarker assay service: p
Molecular Metabolism LLC. offers off-the-shelf protein biomarker discovery and qualification assays with a focus in Oncology and Central Nervous System (CNS) disease areas. We also provide custom protein biomarker discovery and qualification assay develop
-
translationalcancermedicine.com
Translational Cancer Medicine - Day 1
The increasing technological advances in biomarker and target discovery, pre-clinical models, personalized medicine, and clinical trial design have the potential to expedite the translation of new discoveries to clinical practice. Oncology is the area tha
-
biolympus.net
Biolympus Spin-off, Biomarker discovery
Biolympus is a leading spin-off company specialized in the identification, discovery and investigation of immunolobiological, autoimmune and malignant disorders
-
diagen.net
Diagen Corporation - A leader in early stage cancer diagnosis.
DIAGEN Corporation's goal is to become a leader in the discovery and development of immunologically selected biomarkers for the early detection and treatment of cancer and other diseases. DIAGEN is focused on the research and development of immuno se
-
letstestnow.com
Biomarker Testing for Advanced Non Small Cell Lung Cancer (NSCLC) | Let's Test Now
From Boehringer Ingelheim Oncology, information on biomarker testing in advanced non small cell lung cancer (NSCLC)
-
cancerbiomarker.com
Cancer Biomarker - Home Page
Early cancer detection by cancer biomarker is an exciting field. In addition to genetic biomarker, multiple types of cancer biomarkers have been identified. The site attempts at educating visitors on cancer biomarkers.
-
letstest.com
Biomarker Testing for Advanced Non Small Cell Lung Cancer (NSCLC) | Let's Test Now
From Boehringer Ingelheim Oncology, information on biomarker testing in advanced non small cell lung cancer (NSCLC)
-
ngaltest.com
NGAL Test - A key biomarker in drug development and cancer research.
NGAL is a biomarker of acute kidney injury and tissue inflammation, and a valuable tool in drug development and cancer research.
-
nsclc-alk-testing.com
Biomarker Testing for Advanced Non Small Cell Lung Cancer (NSCLC) | Let's Test Now
From Boehringer Ingelheim Oncology, information on biomarker testing in advanced non small cell lung cancer (NSCLC)
-
nsclc-biomarkertest.com
Biomarker Testing for Advanced Non Small Cell Lung Cancer (NSCLC) | Let's Test Now
From Boehringer Ingelheim Oncology, information on biomarker testing in advanced non small cell lung cancer (NSCLC)
-
cintec-cytology.com
CINtec® p16 objective biomarker products help identify cervical pre-cancer
CINtec® p16 (E6H4) immunohistochemistry detects the over-expression of the cellular protein p16INK4a in cervical tissue and cytology specimens correlated with hrHPV-mediated oncogenic transformation.
-
cintec-histology.com
CINtec® p16 objective biomarker products help identify cervical pre-cancer
CINtec® p16 (E6H4) immunohistochemistry detects the over-expression of the cellular protein p16INK4a in cervical tissue and cytology specimens correlated with hrHPV-mediated oncogenic transformation.
-
cintecp16.com
CINtec® p16 objective biomarker products help identify cervical pre-cancer
CINtec® p16 (E6H4) immunohistochemistry detects the over-expression of the cellular protein p16INK4a in cervical tissue and cytology specimens correlated with hrHPV-mediated oncogenic transformation.
-
Molecular Metabolism LLC. | Formerly NextGen Sciences | protein biomarker assay service: p
Molecular Metabolism LLC. offers off-the-shelf protein biomarker discovery and qualification assays with a focus in Oncology and Central Nervous System (CNS) disease areas. We also provide custom protein biomarker discovery and qualification assay develop
2 websites blocked by safe search filter.
